| Clinical and molecular genetics of the phosphodiesterases (PDEs) MF Azevedo, FR Faucz, E Bimpaki, A Horvath, I Levy, RB de Alexandre, ... Endocrine reviews 35 (2), 195-233, 2014 | 339 | 2014 |
| The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and … CA Stratakis, MA Tichomirowa, S Boikos, MF Azevedo, M Lodish, ... Clinical genetics 78 (5), 457-463, 2010 | 228 | 2010 |
| Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients L Vilar, MC Freitas, LA Naves, LA Casulari, M Azevedo, R Montenegro, ... Journal of endocrinological investigation 31, 436-444, 2008 | 205 | 2008 |
| Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH? P Xekouki, K Pacak, M Almeida, CA Wassif, P Rustin, M Nesterova, ... The Journal of Clinical Endocrinology & Metabolism 97 (3), E357-E366, 2012 | 187 | 2012 |
| Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway T Palumbo, FR Faucz, M Azevedo, P Xekouki, D Iliopoulos, CA Stratakis Oncogene 32 (13), 1651-1659, 2013 | 164 | 2013 |
| Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing’s disease L Vilar, LA Naves, MF Azevedo, MJ Arruda, CM Arahata, L Moura e Silva, ... Pituitary 13, 123-129, 2010 | 161 | 2010 |
| Controversial issues in the management of hyperprolactinemia and prolactinomas–An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and … L Vilar, J Abucham, JL Albuquerque, LA Araujo, MF Azevedo, ... Archives of endocrinology and metabolism 62 (2), 236-263, 2018 | 147 | 2018 |
| Snapin mediates incretin action and augments glucose-dependent insulin secretion WJ Song, M Seshadri, U Ashraf, T Mdluli, P Mondal, M Keil, M Azevedo, ... Cell metabolism 13 (3), 308-319, 2011 | 128 | 2011 |
| Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene LA Naves, AF Daly, JF Vanbellinghen, LA Casulari, C Spilioti, ... European Journal of Endocrinology 157 (4), 383-391, 2007 | 109 | 2007 |
| Selenoprotein-Related Disease in a Young Girl Caused by Nonsense Mutations in the SBP2 Gene MF Azevedo, GB Barra, LA Naves, LF Ribeiro Velasco, ... The Journal of Clinical Endocrinology & Metabolism 95 (8), 4066-4071, 2010 | 108 | 2010 |
| Identification of novel genetic variants in phosphodiesterase 8B ( PDE8B ), a cAMP‐specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort … A Rothenbuhler, A Horvath, R Libé, FR Faucz, A Fratticci, ... Clinical endocrinology 77 (2), 195-199, 2012 | 80 | 2012 |
| A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas CL Boguszewski, CMC dos Santos, KS Sakamoto, LC Marini, ... Pituitary 15, 44-49, 2012 | 72 | 2012 |
| Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR L Vilar, MF Azevedo, LA Naves, LA Casulari, JL Albuquerque, ... Pituitary 14, 148-156, 2011 | 71 | 2011 |
| Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS … MQ Almeida, MF Azevedo, P Xekouki, EI Bimpaki, A Horvath, MT Collins, ... The Journal of Clinical Endocrinology & Metabolism 97 (4), E687-E693, 2012 | 68 | 2012 |
| Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment I Levy, A Horvath, M Azevedo, RB de Alexandre, CA Stratakis Current opinion in pharmacology 11 (6), 689-697, 2011 | 64 | 2011 |
| Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas EC Garcia, LA Naves, AO Silva, LF de Castro, LA Casulari, MF Azevedo Pituitary 16, 189-194, 2013 | 56 | 2013 |
| Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways P Xekouki, M Azevedo, CA Stratakis Expert review of endocrinology & metabolism 5 (5), 697-709, 2010 | 55 | 2010 |
| KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn’s syndrome P Xekouki, MM Hatch, L Lin, M Azevedo, M de la Luz Sierra, I Levy, ... Endocrine-related cancer 19 (3), 255, 2012 | 45 | 2012 |
| The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome L Vilar, MC Freitas, LA Naves, V Canadas, JL Albuquerque, CA Botelho, ... Journal of Endocrinological Investigation 31, 1008-1013, 2008 | 41 | 2008 |
| Association of the rs7903146 single nucleotide polymorphism at the Transcription Factor 7-like 2 (TCF7L2) locus with type 2 diabetes in Brazilian subjects GB Barra, LAS Dutra, SC Watanabe, PGG Costa, PSM Cruz, MF Azevedo, ... Arquivos Brasileiros de Endocrinologia & Metabologia 56, 479-484, 2012 | 39 | 2012 |
